Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01630577
Other study ID # CVPChallenge
Secondary ID
Status Completed
Phase Phase 3
First received June 21, 2012
Last updated May 4, 2016
Start date January 2012
Est. completion date May 2013

Study information

Verified date May 2016
Source University of Monastir
Contact n/a
Is FDA regulated No
Health authority Tunisia: Ministry of Public Health
Study type Interventional

Clinical Trial Summary

We conducted this study to assess the value of early change in central venous pressure (CVP) in predicting fluid responsiveness in mechanically ventilated patients.


Description:

In patients with shock a primary goal of treatment is to restore and maintain organ perfusion, for which an adequate cardiac preload is required. Apart from the situations in which hypovolemia is evident and a favourable response to fluid administration will be seen, clinical and biological parameters often fail to predict hypovolemia. Inappropriate use of volume expansion carries out the risk of generating volume overload and pulmonary oedema. Consequently, reliable predictors of fluid responsiveness are needed especially in the early phase of cardiocirculatory deterioration. In the clinical setting, different static and dynamic indices have been shown to be useful indicators of cardiac preload. Central venous pressure (CVP) is widely used to measure right ventricular preload in patients requiring invasive hemodynamic monitoring. However, the use of the CVP is much criticized because CVP poorly predicts cardiac preload and volume status. However several decades ago, Weil and Henning proposed the fluid challenge technique, based on the 2-5 rule using CVP. There is a method for guiding volume repletion based on measurements of the patient's response to fluid load. This method has not been validated in the prediction of fluid responsiveness. We therefore conducted a prospective study that in all patients we measured CVP change and stroke volume variation (SVV) after administration of fluids. Patients were classified as fluid responders when their SVV is >10% after volume expansion and non-responders if SVV is ≤10%.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date May 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- mechanically ventilated patients

- acute circulatory failure defined by the need of vasopressive drugs (dopamine >5µg/kg/per minute or norepinephrine) with signs of tissue hypoperfusion (e.g., altered mental state, mottled skin, urine output below 0.5 ml per kilogram of body weight per hour during at least 2 h).

- admission serum lactate level more than 2.5mmol/L

Exclusion Criteria:

- severe hypoxemia defined as a ratio of arterial oxygen pressure to fraction of inspired oxygen [PaO2/FiO2] < 100 mmHg

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
volume expansion using modified gelatin
Volume expansion using modified gelatin was determined according to a procedure formulated by modifying guidelines produced by Weil and Henning. The maximum volume infusion during the study test was fixed at 400 ml.

Locations

Country Name City State
Tunisia CHU Fattouma Bourguiba Monastir
Tunisia Emergency Department FB University Hospital Monastir

Sponsors (1)

Lead Sponsor Collaborator
University of Monastir

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary fluid challange responsiveness change of Stroke volume variation (SVV) by more than 10% within 20 minutes of fluid challenge Yes
See also
  Status Clinical Trial Phase
Completed NCT03225378 - Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU
Completed NCT03680963 - Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure: N/A
Terminated NCT01090791 - FLOTRAC/VIGILEO in Acute Circulatory Failure N/A
Completed NCT04337983 - Hemodynamic Characteristics of Patients With SARS-CoV-2
Recruiting NCT04946643 - Subclavian Vein Diameter Variations to Assess Vascular Filling
Recruiting NCT03788772 - Systems Analysis of Antigen Presenting Cells in Human Sepsis N/A
Completed NCT04360304 - Assessment of Agreement Between Two Measurement Methods of Left Ventricular Outflow Tract (LVOT) Velocity Time Integral (VTI) N/A
Completed NCT02050269 - Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study Phase 3
Recruiting NCT05046340 - Applicability of Fluid Responsiveness Indices in Circulatory Failure (AFRIC Study) Study Project
Completed NCT04250389 - Microcirculatory Effects of Methylene Blue
Recruiting NCT05613647 - Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
Completed NCT05847998 - Second Generation DICART Prototype Validation N/A
Not yet recruiting NCT06384287 - Peripheral Tissue Perfusion in Intensive Care
Recruiting NCT02878369 - Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test N/A
Completed NCT03694717 - Time Course Evolution of Cardiac Output